EFKO is one of the largest food manufacturers in Russia. It is an innovative company engaged in developing advanced technologies and creating new lines of business based on them.
One of the EFKO's key investment areas is biotechnology. The company's package of biotechnological projects includes sweet protein, cellular nutrition, lipid biosynthesis, and enzymes. EFKO's most commercial-ready biotechnological product is sweet protein. This product has a unique feature: it is several thousand times sweeter than sugar and doesn’t stimulate insulin secretion. In 2024 sweet protein was allowed to enter the market of the Russian Federation and the EAEU countries. The Company is currently developing food formulations which include sweet protein as well as researching their positive impact on human health.